FGF9 and ovarian carcinoma: In ovarian cancer, circITGB6 directly interacts with IGF2BP2 and FGF9 mRNA, stabilizing FGF9 mRNA and inducing TAM polarization towards the M2 phenotype, increasing ovarian cancer’s resistance to cisplatin594 (Fig. 5).